TRIMEDX has named a new chief executive with healthcare IT experience as the clinical asset management company looks to build on its recent expansion and technological innovations.
TRIMEDX—an independent clinical asset management company specializing in clinical engineering services, clinical asset informatics, and medical device cybersecurity—has announced that Neil de Crescenzo will assume the role of chief executive officer, effective April 2.
He succeeds Henry Hummel, who has served as CEO since 2017 and will transition to chair of the TRIMEDX board of directors.
Healthcare Information Technology Experience
de Crescenzo brings decades of experience in healthcare information technology and technology-enabled services. Most recently, he served as CEO of Optum Insight, a technology-enabled services organization with $19 billion in revenue. Previously, he was president, CEO, and board member of Change Healthcare, a NASDAQ-listed healthcare software and technology-enabled services company, which was acquired by UnitedHealth Group for $13 billion in 2022.
Earlier in his career, de Crescenzo held leadership positions at Oracle Corporation and IBM Corporation. He currently serves on the board of directors of CCC Intelligent Solutions, an enterprise software provider for the property and casualty insurance industry. Most recently, he was a senior advisor at Blackstone Group after departing UnitedHealth Group in 2023.
“I am honored to join TRIMEDX as CEO and build upon the strong foundation established by Henry and the entire leadership team. TRIMEDX has set the standard in clinical asset management, leveraging technology and data-driven insights to enhance patient care and operational efficiency, enabled by a culture of empowerment, caring, innovation, and customer focus,” says de Crescenzo in a release. “I am excited to be working with our associates on our next phase of innovation and growth, continuing to provide exceptional service to our clients and making a meaningful impact in healthcare.”
TRIMEDX’s new CEO holds a BA in political science from Yale University and an MBA from Northeastern University. He has served on the boards of the Nashville Health Care Council and the Middle Tennessee American Heart Association. He is a trustee of the Committee for Economic Development of the Conference Board and was chairman and a long-time executive committee member of the Healthcare Leadership Council in Washington, DC.
Growth Under Hummel’s Leadership
de Crescenzo steps into a company that has seen growth and transformation under Hummel’s leadership, according to a release from TIRMEDX, which notes that, since 2017, Hummel has strengthened TRIMEDX’s position in clinical asset management, emphasizing innovation, workplace excellence, and industry recognition. During Hummel’s tenure, TRIMEDX tripled in size, expanding from approximately 1,200 associates serving 1,800 locations to over 3,200 associates supporting nearly 6,000 locations, according to the company.
A key milestone in this growth was the 2018 acquisition of Aramark’s Healthcare Technologies business, which nearly doubled the company’s workforce and service capabilities. In 2020, TRIMEDX further expanded its portfolio with the acquisition of Centurion Service Group, specializing in surplus medical equipment management, integrating proprietary pricing data and auction services into its platform.
Hummel also spearheaded TRIMEDX’s advancements in technology solutions, enhancing clinical engineering, asset management, and cybersecurity services. These innovations include the launch of Vigilor in 2023, an expansion of its medical device cybersecurity solutions, and the introduction of GeoSense in 2024, a real-time location system providing greater visibility into medical device inventories.
“I am incredibly proud of what we have accomplished at TRIMEDX. The company has grown tremendously, expanded its capabilities, and remained committed to providing innovative solutions that deliver persistent value to our clients and associates,” says Hummel in a release. “I have full confidence that under Neil’s leadership, TRIMEDX will continue to thrive, driving forward new advancements in clinical asset management and making a lasting impact on the industry.”
Photo caption: Neil de Crescenzo
Photo credit: TRIMEDX
